Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
ESC Congress to highlight results from global trials in six press conferences

ESC Congress to highlight results from global trials in six press conferences

Mild head injury patients having lower serum S100B levels unlikely to have intracranial hemorrhage

Mild head injury patients having lower serum S100B levels unlikely to have intracranial hemorrhage

Substantial pharmacogenetic information available on cardiovascular drugs

Substantial pharmacogenetic information available on cardiovascular drugs

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Use of balloon-expandable stent compared with medical therapy increases stroke risk

Use of balloon-expandable stent compared with medical therapy increases stroke risk

Researchers find key protein critical to the success of common anti-platelet drug Plavix

Researchers find key protein critical to the success of common anti-platelet drug Plavix

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Ambulance administration of antiplatelet medication may help heart attack patients

Ambulance administration of antiplatelet medication may help heart attack patients

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Genetic variants linked to race that explains risk of death among patients taking Plavix after heart attack

Genetic variants linked to race that explains risk of death among patients taking Plavix after heart attack

Anticoagulation therapy with low-dose aspirin can be used with new generation mechanical heart valve

Anticoagulation therapy with low-dose aspirin can be used with new generation mechanical heart valve

New angiographic analysis examines impact of stent thrombosis in patients undergoing PCI

New angiographic analysis examines impact of stent thrombosis in patients undergoing PCI

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Cardiologists question FDA recommendations on genetic testing before taking Plavix

STSI receives $29M grant to support innovative research on genomics, wireless technology and bioinformatics

STSI receives $29M grant to support innovative research on genomics, wireless technology and bioinformatics

Ticagrelor drug may reduce risk of dying following heart attack

Ticagrelor drug may reduce risk of dying following heart attack

Coronary artery bypass graft surgery provides better health status, quality of life in diabetic patients

Coronary artery bypass graft surgery provides better health status, quality of life in diabetic patients